• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Tan Meng Dong (James) acquired 2,779,000 units of Ordinary Shares and bought 292,250 units of Ordinary Shares

    11/25/22 9:57:07 PM ET
    $LAX
    Get the next $LAX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Tan Meng Dong (James)

    (Last) (First) (Middle)
    6 EU TONG SEN STREET #08-13

    (Street)
    SINGAPORE 059817

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    EUDA Health Holdings Ltd [ EUDA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    11/17/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Ordinary Shares 11/17/2022 J 2,776,000 A (1) 2,776,000 D
    Ordinary Shares 2,141,250 I See Footnote(2)
    Ordinary Shares 11/24/2021 J 3,000 A (3) 3,000 D
    Ordinary Shares 11/24/2021 P 292,250 A (4) 292,250 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Warrants $11.5 11/24/2021 P 292,250 (5) (6) Ordinary shares 146,125 (4) 292,250 D
    Rights (7) 11/24/2021 P 292,250 (7) (7) Ordinary shares 29,225 (4) 292,250 D
    Explanation of Responses:
    1. The securities reported here were received from Mr. Tan's through his redemption of 8i Capital Limited's and 8i Enterprises Pte Ltd.'s holdings in Watermark Developments Limited at the closing of EUDA Health Holdings Limited's business combination with EUDA Health Limited. The total capital contribution that Mr. Tan invested was $400,000 prior to redemption.
    2. The securities reported herein are held by 8i Holdings 2 Pte. Ltd. and may be deemed to be indirectly beneficially owned by Mr. Meng Dong (James) Tan. Mr. Tan disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
    3. The shares were transferred to Mr. Meng Dong (James) Tan from 8i Holdings 2 Pte. Ltd.
    4. The reporting person acquired 292,250 units consisting of ordinary shares, warrants and rights at a purchase price of $10.00 per share.
    5. The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.
    6. The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.
    7. The rights convert automatically into ordinary shares at the completion of the registrant's initial business combination.
    /s/ Meng Dong (James) Tan 11/25/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAX
    SEC Filings

    View All

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/22/24 9:30:30 PM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/17/24 6:10:06 AM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    12/29/23 5:03:20 PM ET
    $LAX

    $LAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/20/23 3:19:26 PM ET
    $LAX

    SEC Form 3: New insider Wong Kongyew claimed no ownership of stock in the company

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/8/23 8:31:59 PM ET
    $LAX

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    5/26/23 8:42:17 AM ET
    $LAX

    $LAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination

    Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Ltd ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" (NASDAQ:EUDA) and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on N

    11/23/22 4:32:15 PM ET
    $LAX

    8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination

    Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Limited ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on November 18, 202

    11/17/22 5:23:47 PM ET
    $LAX

    8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption

    Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ:LAX, the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company's business combination with EUDA Health Limited were approved by shareholders. Holders of Company's ordinary shares that elected to redeem shares in connection with the Company's special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in

    11/10/22 4:01:00 PM ET
    $LAX

    $LAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13D/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    5/26/23 8:44:16 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/14/23 10:13:57 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/7/23 4:59:19 PM ET
    $LAX